Remicade (infliximab) 100 mg powder for concentrate for solution for infusion, 1 vial (Merck Sharp ) Infliximab Rheumatoid arthritis. Drug delivery from Europe and beyond, storage compliance, payment upon receipt. Order by calling +380996042415, Viber, WhatsApp.

Active rheumatoid arthritis in patients 18 years of age and older (in combination with methotrexate) when previous therapy, including methotrexate, has been ineffective.

Severe active Crohn's disease (including fistula formation) in patients 18 years of age and older that is refractory to standard therapy, including corticosteroids and/or immunosuppressants.

Moderate or severe active Crohn's disease in children and adolescents aged 6 to 17 years inclusive - when standard therapy, including corticosteroids and/or immunosuppressants, is ineffective, intolerable, or contraindicated.

Ulcerative colitis in adults when standard therapy has been ineffective. therapy.

Moderate to severe ulcerative colitis in children and adolescents aged 6 to 17 years - when standard therapy with corticosteroids, 6-mercaptopurine, or azathioprine is ineffective, or in the presence of intolerance or contraindications to standard therapy.

Ankylosing spondylitis.

Psoriatic arthritis.

Psoriasis.